GemcitabineReversible posterior leukoencephalopathy syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2009年 / 1272卷 / 1期

关键词：

Clinical Trial; Lung Cancer; Cell Lung Cancer; Gemcitabine; Small Cell Lung Cancer;

D O I：

10.2165/00128415-200912720-00054

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：18 / 18

相关论文

共 50 条

[41] RivoceranibReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2020, 1811 (1) : 242 - 242
[42] CytarabineReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2007, 1155 (1) : 8 - 8
[43] SirolimusReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2012, 1385 (1) : 40 - 40
[44] RituximabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2010, 1309 (1) : 36 - 36
[45] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2006, 1128 (1) : 8 - 8
[46] AxitinibReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2022, 1896 (1) : 62 - 62
[47] RivoceranibReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2020, 1786 (1) : 148 - 148
[48] LenalidomideReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2012, 1413 (1) : 31 - 31
[49] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2014, 1504 (1) : 7 - 7
[50] PrednisoloneReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2011, 1346 (1) : 34 - 34

← 1 2 3 4 5 →